Clinical Roundup Alunbrig demonstrates reduced risk of death, disease progression in ALK+ NSCLC December 06, 2019Vol.45 No.45
Clinical Roundup Experimental targeted therapy may be better for repeat kidney cancer patients than FDA-approved counterpart, study finds December 06, 2019Vol.45 No.45
Clinical Roundup Duke researchers develop technique to visually depict how cancer cells grow and spread in colon tissue December 06, 2019Vol.45 No.45
Clinical Roundup Care in a multidisciplinary prostate cancer clinic increases discussion of treatment options, adherence to guidelines November 22, 2019Vol.45 No.44
Clinical Roundup UCSD researchers focus on persistent opioid use, abuse and toxicity among cancer survivors November 22, 2019Vol.45 No.44
Clinical Roundup In Opdivo + Yervoy vs. Opdivo alone in resected high-risk melanoma and PD-L1 <1% does not meet primary endpoints November 22, 2019Vol.45 No.44
Clinical Roundup Phase III trial of Ninlaro as first-line maintenance therapy meets PFS in multiple myeloma November 08, 2019Vol.45 No.42
Clinical Roundup Inovio demonstrates 80% 6-month PFS in phase II glioblastoma multiforme study with INO-5401 + Libtayo November 08, 2019Vol.45 No.42
Clinical Roundup AppliedVR and NCI evaluate virtual reality to address cancer-related anxiety November 08, 2019Vol.45 No.42
Clinical Roundup Thermo Fisher Scientific introduces NGS platform that delivers faster results November 08, 2019Vol.45 No.42
